Literature DB >> 27056601

Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Christoph Rischpler1, Ralf J Dirschinger1, Stephan G Nekolla1, Hans Kossmann1, Stefania Nicolosi1, Franziska Hanus1, Sandra van Marwick1, Karl P Kunze1, Alexander Meinicke1, Katharina Götze1, Adnan Kastrati1, Nicolas Langwieser1, Tareq Ibrahim1, Matthias Nahrendorf1, Markus Schwaiger1, Karl-Ludwig Laugwitz2.   

Abstract

BACKGROUND: The immune system orchestrates the repair of infarcted myocardium. Imaging of the cellular inflammatory response by (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/magnetic resonance imaging in the heart has been demonstrated in preclinical and clinical studies. However, the clinical relevance of post-MI (18)F-FDG uptake in the heart has not been elucidated. The objective of this study was to explore the value of (18)F-FDG positron emission tomography/magnetic resonance imaging in patients after acute myocardial infarction as a biosignal for left ventricular functional outcome. METHODS AND
RESULTS: We prospectively enrolled 49 patients with ST-segment-elevation myocardial infarction and performed (18)F-FDG positron emission tomography/magnetic resonance imaging 5 days after percutaneous coronary intervention and follow-up cardiac magnetic resonance imaging after 6 to 9 months. In a subset of patients, (99m)Tc-sestamibi single-photon emission computed tomography was performed with tracer injection before revascularization. Cellular innate immune response was analyzed at multiple time points. Segmental comparison of (18)F-FDG-uptake and late gadolinium enhancement showed substantial overlap (κ=0.66), whereas quantitative analysis demonstrated that (18)F-FDG extent exceeded late gadolinium enhancement extent (33.2±16.2% left ventricular myocardium versus 20.4±10.6% left ventricular myocardium, P<0.0001) and corresponded to the area at risk (r=0.87, P<0.0001). The peripheral blood count of CD14(high)/CD16(+) monocytes correlated with the infarction size and (18)F-FDG signal extent (r=0.53, P<0.002 and r=0.42, P<0.02, respectively). (18)F-FDG uptake in the infarcted myocardium was highest in areas with transmural scar, and the standardized uptake valuemean was associated with left ventricular functional outcome independent of infarct size (Δ ejection fraction: P<0.04, Δ end-diastolic volume: P<0.02, Δ end-systolic volume: P<0.005).
CONCLUSIONS: In this study, the intensity of (18)F-FDG uptake in the myocardium after acute myocardial infarction correlated inversely with functional outcome at 6 months. Thus, (18)F-FDG uptake in infarcted myocardium may represent a novel biosignal of myocardial injury.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  18-fluorodeoxyglucose; inflammation; magnetic resonance imaging; monocytes; myocardial infarction; positron emission tomography

Mesh:

Substances:

Year:  2016        PMID: 27056601      PMCID: PMC4826716          DOI: 10.1161/CIRCIMAGING.115.004316

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  45 in total

1.  Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction.

Authors:  Christian Reeps; Ralph A Bundschuh; Jaroslav Pellisek; Michael Herz; Sandra van Marwick; Markus Schwaiger; Hans-Henning Eckstein; Stephan G Nekolla; Markus Essler
Journal:  Int J Cardiovasc Imaging       Date:  2012-07-07       Impact factor: 2.357

2.  Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects.

Authors:  Christoph Rischpler; Stephan G Nekolla; Isabel Dregely; Markus Schwaiger
Journal:  J Nucl Med       Date:  2013-02-12       Impact factor: 10.057

3.  PET/MRI of inflammation in myocardial infarction.

Authors:  Won Woo Lee; Brett Marinelli; Anja M van der Laan; Brena F Sena; Rostic Gorbatov; Florian Leuschner; Partha Dutta; Yoshiko Iwamoto; Takuya Ueno; Mark P V Begieneman; Hans W M Niessen; Jan J Piek; Claudio Vinegoni; Mikael J Pittet; Filip K Swirski; Ahmed Tawakol; Marcelo Di Carli; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

4.  A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.

Authors:  Anja M van der Laan; Alexander Hirsch; Lourens F H J Robbers; Robin Nijveldt; Ingrid Lommerse; Ronak Delewi; Pieter A van der Vleuten; Bart J Biemond; Jaap Jan Zwaginga; Wim J van der Giessen; Felix Zijlstra; Albert C van Rossum; Carlijn Voermans; C Ellen van der Schoot; Jan J Piek
Journal:  Am Heart J       Date:  2011-11-23       Impact factor: 4.749

5.  Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir.

Authors:  Anja M van der Laan; Ellis N Ter Horst; Ronak Delewi; Mark P V Begieneman; Paul A J Krijnen; Alexander Hirsch; Mehrdad Lavaei; Matthias Nahrendorf; Anton J Horrevoets; Hans W M Niessen; Jan J Piek
Journal:  Eur Heart J       Date:  2013-08-21       Impact factor: 29.983

6.  Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.

Authors:  Philipp Heusch; Christian Buchbender; Karsten Beiderwellen; Felix Nensa; Verena Hartung-Knemeyer; Thomas C Lauenstein; Andreas Bockisch; Michael Forsting; Gerald Antoch; Till A Heusner
Journal:  Eur J Radiol       Date:  2013-02-08       Impact factor: 3.528

7.  Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium.

Authors:  Ingo Hilgendorf; Louisa M S Gerhardt; Timothy C Tan; Carla Winter; Tobias A W Holderried; Benjamin G Chousterman; Yoshiko Iwamoto; Ronglih Liao; Andreas Zirlik; Marielle Scherer-Crosbie; Catherine C Hedrick; Peter Libby; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Circ Res       Date:  2014-03-13       Impact factor: 17.367

Review 8.  Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

Authors:  Filip K Swirski; Matthias Nahrendorf
Journal:  Science       Date:  2013-01-11       Impact factor: 47.728

Review 9.  Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction.

Authors:  Ignacio M Seropian; Stefano Toldo; Benjamin W Van Tassell; Antonio Abbate
Journal:  J Am Coll Cardiol       Date:  2014-02-13       Impact factor: 24.094

Review 10.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

View more
  48 in total

Review 1.  Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging.

Authors:  Sadi Loai; Hai-Ling Margaret Cheng
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

2.  Assessment of myocardial viability of a patient with old myocardial infarction by 18F-fluorodeoxyglucose PET/MRI.

Authors:  Atsuro Masuda; Ayaka Nemoto; Takayoshi Yamaki; Noboru Oriuchi; Seiichi Takenoshita; Yasuchika Takeishi
Journal:  J Nucl Cardiol       Date:  2017-06-05       Impact factor: 5.952

Review 3.  Updates on Stress Imaging Testing and Myocardial Viability With Advanced Imaging Modalities.

Authors:  Sandeep S Hedgire; Michael Osborne; Daniel J Verdini; Brian B Ghoshhajra
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

4.  Cardiac PET/MRI enters the clinical arena! Finally….

Authors:  C Rischpler; N Langwieser; S G Nekolla
Journal:  J Nucl Cardiol       Date:  2016-09-23       Impact factor: 5.952

5.  Imaging Cardiovascular and Lung Macrophages With the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs.

Authors:  Matthias Nahrendorf; Friedrich Felix Hoyer; Anu E Meerwaldt; Mandy M T van Leent; Max L Senders; Claudia Calcagno; Philip M Robson; George Soultanidis; Carlos Pérez-Medina; Abraham J P Teunissen; Yohana C Toner; Kiyotake Ishikawa; Kenneth Fish; Ken Sakurai; Esther M van Leeuwen; Emma D Klein; Alexandros Marios Sofias; Thomas Reiner; David Rohde; Aaron D Aguirre; Gregory Wojtkiewicz; Stephen Schmidt; Yoshiko Iwamoto; David Izquierdo-Garcia; Peter Caravan; Filip K Swirski; Ralph Weissleder; Willem J M Mulder
Journal:  Circ Cardiovasc Imaging       Date:  2020-10-20       Impact factor: 7.792

Review 6.  PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

Review 7.  Applications of PET-MR Imaging in Cardiovascular Disorders.

Authors:  Rhanderson Cardoso; Thorsten M Leucker
Journal:  PET Clin       Date:  2020-07-21

8.  Technical aspects of cardiac PET/MRI.

Authors:  Atsuro Masuda; Ayaka Nemoto; Yasuchika Takeishi
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

Review 9.  Clinical imaging of cardiovascular inflammation.

Authors:  Claudia Calcagno; Zahi A Fayad
Journal:  Q J Nucl Med Mol Imaging       Date:  2020-02-18       Impact factor: 2.346

Review 10.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.